ADVANCE HIV study set to save SA billions

aidsribbonsA new HIV drug combination could save SA billions of rands – plus it would be easier and safer for patients to take. Launched on Monday, the ADVANCE study will evaluate a HIV treatment regimen including two newer and cheaper drugs: dolutegravir (DTG) and tenofovir alafenamide (TAF). “If successful, patients will benefit from a much safer and more forgiving drug regimen in a smaller tablet,” said Francois Venter, Deputy Director of the Wits Reproductive Health and HIV Institute (WRHI)……more

Advertisements

Leave a Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s